---
title: Efficacy and safety of bemcentinib in patients with advanced myelodysplastic
  neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase
  II BERGAMO trial
date: '2023-09-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37735558/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230922181057&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...